CytoTerra Inc. — Form D
CytoTerra Inc. of SEATTLE, WA, a company, filed a Form D exempt-offering notice with the SEC on 2026-02-10. The offering totals $2.0M, of which $1.0M was reported sold. Industry: Other Technology.
Offering
- Filed: 2026-02-10
- Form: D
- Accession: 0002109738-26-000001
- Industry: Other Technology
- Exemptions: 06b
- Total offering: $2.0M
- Amount sold: $1.0M
- Remaining: $985K
- Investors: 13
- Date of first sale: 2026-01-28
- Security types: debt
- Revenue range: Decline to Disclose
- SEC file number: 021-573044
Issuer
- Name: CytoTerra Inc.
- CIK: 0002109738
- Entity type: Corporation
- Jurisdiction: DELAWARE
- Incorporated: 2025
- Address: 2815 EASTLAKE AVENUE EAST, SEATTLE, WA, 98102
- Phone: 410-382-8042
Officers, directors & promoters (4)
| Name | Role | Location |
|---|
| Stephen Eacker | Director | SEATTLE, WA |
| Sean MacLeod | Director | SEATTLE, WA |
| Jesse Salk | Director | SEATTLE, WA |
| Stephen Eacker | Executive Officer | SEATTLE, WA |
More